|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10136 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-Perforin |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Perforin |
中文名稱 穿孔素抗體說明書
英文名稱 Anti-Perforin
別 名 Cytolysin; FLH2; HPLH2; Lymphocyte pore forming protein; Lymphocyte pore-forming protein; MGC65093; P1; PERF_HUMAN; Perforin 1; Perforin 1 precursor; Perforin 1 preforming protein; Perforin-1; PFP; PGFL; PIGF; PIGF-2; PLGF; Pore forming protein; PRF 1; PRF1; SHGC-10760.
產(chǎn)品屬性：
穿孔素抗體說明書 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 淋巴細(xì)胞 t-淋巴細(xì)胞
蛋白分子量 predicted molecular weight: 59kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Perforin
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
穿孔素抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The major defense of the body against virus-infected and tumorigenic cells is cytotoxic T lymphocyte (CTL)-mediated cytotoxicity, which also plays a role in autoimmune diseases and transplant rejection. During CTL-mediated cytotoxicity, CTL granules containing perforin are exocytosed. Perforin is a pore-forming protein that facilitates the entry of cytotoxic serine proteases, such as granzymes, into target cells by forming transmembrane channels in target cell membranes. Perforin is primarily expressed in cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, but has also been observed in an astrocyte population of the human brain. It has been shown that abrogation of perforin function by Ca2+-complexing agents leads to decreased levels of necrosis, demonstrating that both necrosis and apoptosis contribute to CTL-mediated cytotoxicity. Perforin activity has been shown to be induced by IL-2, IL-3, IL-4, IL-6 and to a lesser degree, TNF and IFN-γ.
Function : Plays a key role in secretory granule-dependent cell death, and in defense against virus-infected or neoplastic cells. Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease. Can insert into the membrane of target cells in its calcium-bound form, oligomerize and form large pores. Promotes cytolysis and apoptosis of target cells by facilitating the uptake of cytotoxic granzymes.
Subunit : Monomer, as sobluble protein. Homooligomer. Oligomerization is required for pore formation.
Subcellular Location : Cytoplasmic granule lumen. Secreted. Cell membrane. Endosome lumen. Stored in cytoplasmic granules of cytolytic T-lymphocytes and secreted into the cleft between T-lymphocyte and target cell. Inserts into the cell membrane of target cells and forms pores. Membrane insertion and pore formation requires a major conformation change. May be taken up via endocytosis involving clathrin-coated vesicles and accumulate in a first time in large early endosomes.
DISEASE : Defects in PRF1 are the cause of hemophagocytic lymphohistiocytosis familial type 2 (FHL2) [MIM:603553]; also known as HPLH2. Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous, rare autosomal recessive disorder. It is characterized by immune dysregulation with hypercytokinemia and defective natural killer cell function. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia, hypofibrinogenemia, and neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits, and ataxia. Hemophagocytosis is a prominent feature of the disease, and a non-malignant infiltration of macrophages and activated T lymphocytes in lymph nodes, spleen, and other organs is also found.
Similarity : Belongs to the complement C6/C7/C8/C9 family.
Contains 1 C2 domain.
Contains 1 EGF-like domain.
Contains 1 MACPF domain.
Database links : UniProtKB/Swiss-Prot: P14222.1
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
穿孔素抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★穿孔素抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品：
TUBB(Human Beta-tubulin) ELISA kit 人β-微管蛋白Multi-class antibodies規(guī)格： 48T
Anti-MARCKS 丙氨酸蛋白激酶C底物Marcks抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Ki-67 (Proliferation Marker) Ki67蛋白抗體 規(guī)格 0.1ml
TSH ELISA Kit 大鼠促甲狀腺素 96T
PGF2 alpha 英文名稱： 素F2a/PGF2 α抗體 0.2ml
C2orf60 英文名稱： 2號(hào)染色體開放閱讀框60抗體 0.2ml
Anti-MARCKS 丙氨酸蛋白激酶C底物Marcks抗體Multi-class antibodies規(guī)格： 0.1ml
adiponectin(humen) 人脂聯(lián)素Multi-class antibodies規(guī)格： 48T
Anti-CK20 細(xì)胞角蛋白20抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh NRP1/CD304 神經(jīng)纖毛蛋白1抗體 規(guī)格 0.1ml
processing solution 顯影液試劑 200ml
TRF2 英文名稱： 端粒結(jié)合蛋白2抗體 0.1ml
C7orf10 英文名稱： 7號(hào)染色體開放閱讀框10抗體 0.2ml
Anti-CK20 細(xì)胞角蛋白20抗體Multi-class antibodies規(guī)格： 0.2ml
cPLA2(Rat Cytosolic Phospholipase A2,cPLA2 )ELISA Kit 大鼠胞漿型磷脂酶A2Multi-class antibodies規(guī)格： 48T
Anti-Astrocyte 人星形膠質(zhì)細(xì)胞抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Goat Anti-human IgG/Alexa Fluor 350 Alexa Fluor 350標(biāo)記的羊抗人IgG 規(guī)格 0.1ml
(Mouse anti-IVIgG antibody) ELISA Kit 小鼠抗IVIgG抗體 96T
NKX6.1 英文名稱： 轉(zhuǎn)錄因子相關(guān)蛋白NKX6.1抗體 0.2ml
Phospho-Bad (Ser118) 英文名稱： 磷酸化相關(guān)死亡促進(jìn)因子抗體 0.1ml
Anti-Astrocyte 人星形膠質(zhì)細(xì)胞抗體Multi-class antibodies規(guī)格： 0.2ml
人間充質(zhì)干細(xì)胞-脂肪
NCI-H661 人大細(xì)胞細(xì)胞
ACE2 Others Rat 大鼠 ACE2 / ACEH 人細(xì)胞裂解液 (陽性對(duì)照)
mOPC, 小鼠少突膠質(zhì)前體細(xì)胞
人胚胎心肌組織來源細(xì)胞;CCC-HEH-2
人胚;IMR-90 人淋巴內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL
CL-0215SK-OV-3(人細(xì)胞)5×106cells/瓶×2
APOM Others Human 人 APOM 人細(xì)胞裂解液 (陽性對(duì)照)
小鼠骨髓基質(zhì)細(xì)胞完全培養(yǎng)基 100mL
PK(15)豬腎上皮細(xì)胞 PK (15) of porcine kidney epithelial cells MEM+10% FBS
IL18BP Protein Human 重組人 IL18BPa 蛋白 (His 標(biāo)簽)
QGY-7703(人細(xì)胞) 5×106cells/瓶×2 7721(7721細(xì)胞)
穿孔素抗體說明書 人間充質(zhì)干細(xì)胞-脂肪
NCI-H661 人大細(xì)胞細(xì)胞
ACE2 Others Rat 大鼠 ACE2 / ACEH 人細(xì)胞裂解液 (陽性對(duì)照)
mOPC, 小鼠少突膠質(zhì)前體細(xì)胞
人胚胎心肌組織來源細(xì)胞;CCC-HEH-2
人胚;IMR-90 人淋巴內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL
|
|
|
|
|
